ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231

BACKGROUND: Platinum-based drugs are used extensively in neoadjuvant chemotherapy for triple-negative breast cancer (TNBC), but their use can be limited by resistance. In this study, we established cisplatin (DDP) resistant TNBC cells to investigate the potential relationship among ETS1, IKKα/NF-κB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuzhu, Wu, Jingjing, Ye, Meina, Wang, Bing, Sheng, Jiayu, Shi, Bailing, Chen, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009945/
https://www.ncbi.nlm.nih.gov/pubmed/29950928
http://dx.doi.org/10.1186/s12935-018-0581-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009945/
https://www.ncbi.nlm.nih.gov/pubmed/29950928
http://dx.doi.org/10.1186/s12935-018-0581-4

Ejemplares similares